TOKENPOST
1 min read
Add as a preferred source on Google

Scribe Therapeutics Posts $0.68 Q3 GAAP Loss Per Share, Beats Estimate

Revenue totaled $1.6 million, missing estimates by $2.12 million.

By John Kim
Published
A blank report booklet sits on a tilted brass balance scale / TokenPost.ai
A blank report booklet sits on a tilted brass balance scale / TokenPost.ai

Scribe Therapeutics Inc. (SCTX) posted a third-quarter GAAP loss of $0.68 per share, 20 cents better than estimates, while revenue missed estimates by $2.12 million.

Revenue totaled $1.6 million.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…